ImClone Reviews

3.3

52% would recommend to a friend

(39 total reviews)

Jerry Kinzel

100% approve of CEO

23% positive business outlook

ImClone has an employee rating of 3.3 out of 5 stars, based on 39 company reviews on Glassdoor which indicates that most employees have a good working experience there. The ImClone employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical and biotechnology industry (3.5 stars).

Reviews by job title

39 reviews
1.0
18 May 2015
Recommend
CEO approval
Business outlook

Pros

Great pipeline and research environment

Cons

Management in NY ruthless and clueless

2.0
15 Apr 2009
Recommend
CEO approval
Business outlook

Pros

The pipeline is promising. Several compounds are headed for phase three. The benefits are very competitive; the compensation is middle of the road. The offices and manufacturing facilities are generally fairly new and pleasant places to work.

Cons

The management is very weak. The organization is very immature. There is a good possibility of more layoffs due to the Lilly merger later this year. The Lilly consent decree (Zyprexa) affects ImClone employees as well. The transfer of ownership from Icahn to Lilly has been very disruptive.

1.0
29 Nov 2012

Not for those who want job satisfaction

Anonymous employee
Recommend
CEO approval
Business outlook

Pros

The New York office/labs are really beautiful with great views

Cons

Upper management is more concerned with filling their quota's and not your projects. Poor salary compensation awful employee morale

Viewing 1 - 3 of 39 Reviews

Glassdoor has 45 ImClone reviews submitted anonymously by ImClone employees. Read employee reviews and ratings on Glassdoor to decide if ImClone is right for you.